Shift comes with $5 million dedication to launch Cencora’s healthier futures grant program.
Cencora Inc., broke the news that it has completed a name and stock ticker change from AmerisourceBergen Corporation. As part of the announcement, Cencora plans on donating $5 million to the Cencora Impact Foundation, with the purpose of launching the Cencora Healthier Futures Grant Program. The program will aim to dentify opportunities to support those on the front lines of healthcare in underserved populations who are driving innovation in global health.
"Today is a significant and exciting milestone for Cencora. Our new name is a reminder of our customers, their patients, and our team members who are at the center of everything we do,” said Steven H. Collis, chairman, president, CEO, Cencora. “It represents the healthier futures we strive for serving as a trusted industry partner that prioritizes innovation, advocates for patient access, and advances strategic partnerships across the global pharmaceutical value chain.”
Reference: AmerisourceBergen becomes Cencora, in alignment with the company’s growing global footprint and central role in pharmaceutical access and care. Cencora. August 30, 2023. Accessed August 31, 2023. https://www.cencora.com/newsroom/press-releases/amerisourcebergen-becomes-cencora
The Misinformation Maze: Navigating Public Health in the Digital Age
March 11th 2025Jennifer Butler, chief commercial officer of Pleio, discusses misinformation's threat to public health, where patients are turning for trustworthy health information, the industry's pivot to peer-to-patient strategies to educate patients, and more.
Navigating Distrust: Pharma in the Age of Social Media
February 18th 2025Ian Baer, Founder and CEO of Sooth, discusses how the growing distrust in social media will impact industry marketing strategies and the relationships between pharmaceutical companies and the patients they aim to serve. He also explains dark social, how to combat misinformation, closing the trust gap, and more.